An FDA panel with ties to the industry recommended loosening regulations on six peptides over objections from FDA scientists over a lack of data. Peptides have been for everything from faster healing to younger-looking skin and a longer lifespan, despite little evidence that they actually work and are safe. Getty Images fileJuly 24, 2026, 5:17 PM EDTA Food and Drug Administration advisory committee on Friday recommended allowing two more unproven peptides to be compounded, capping a two-day meeting that raised questions about whether the agency was weakening the guardrails designed to keep untested drugs from reaching patients.Just a moment.We are getting your experience ready.
‘Pandora’s box’: FDA peptide votes could open the door to more unproven drugs
An FDA panel with ties to the industry recommended loosening regulations on six peptides over objections from FDA scientists over a lack of data.
104 words~1 min read
